0422

We celebrate the best that the pharma industry has to offer with the 2022 Power List, the inaugural Company of the Year Awards, and the grand winner of the Innovation Awards. Also in this issue, experts share their thoughts on mRNA analysis, Industry 4.0, and flexible cleanrooms. Ukrainian company Enamine explains how drug discovery has been affected by Russia’s Ukraine invasion, and we speak with Novo Nordisk’s Ludovic Helfgott about rare diseases.

Register to download

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Business & Regulation Business Practice

Celebrating the Pharma Industry’s Most Inspirational People and Companies

05/03/2022

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

Business & Regulation Standards & Regulation

An Ode to Flexible Cleanroom Furniture

03/25/2022 | Sue Springett

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

Business & Regulation Advanced Medicine

Champions of Cell and Gene Therapy

04/26/2022 | Angus Stewart

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

Manufacture Bioprocessing - Upstream & Downstream

uBioprocess

03/21/2022 | Angus Stewart

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

Manufacture Bioprocessing - Upstream & Downstream

Welcome to the Microbe Factory

03/23/2022 | Axel Erler

How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?

Discovery & Development Business Practice

“We Want to Return to the Lab”: How the Russian Invasion Has Disrupted Drug Discovery in Ukraine

03/07/2022 | Angus Stewart

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

Business & Regulation Business Practice

Done Deal: Creating Anti-COVID-19 Equity

04/05/2022 | Maryam Mahdi

Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.

Discovery & Development Analytical Science

Top Tips for mRNA Sequencing

02/21/2022

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.

Manufacture Digital Technologies

Industry 4.0: The Invisible Hand

03/08/2022 | Angus Stewart

Yvonne Duckworth lays out insights into Pharma 4.0 gleaned in a recent report by CRB. VR, AR, AI: is it more than just alphabet soup?

Business & Regulation Business Practice

Speaking the Language of Pharmaceutical Success

04/12/2022 | Maryam Mahdi

We sat down to talk shop with Novo Nordisk Executive Vice President Ludovic Helfgott

Other issues of 2022